<?xml version="1.0" encoding="UTF-8"?>
<p id="p0004" num="0004" sourceFile="EPÂ 2036902A2.xml">US Patent Numbers, 
  <patcit id="pcit0005" dnum="US3424760A">
    <text>US 3,424,760</text>
  </patcit> and 
  <patcit id="pcit0006" dnum="US3424761A">
    <text>US 3,424,761</text>
  </patcit> both describe a series of 3-Ureidopyrrolidines that are said to exhibit analgesic, central nervous system, and pyschopharmacologic activities. These patents specifically disclose the compounds 1-(1-phenyl-3-pyrrolidinyl)-3-phenyl urea and 1-(1-phenyl-3-pyrrolidinyl)-3-(4-methoxyphenyl)urea respectively.
</p>
